Given that the PIK3CA mutation is frequent in BCs, PD-L1, c-Met, and MSI/dMMR might considerably affect BCs, thus, implying that these markers would be tumor behavior-related biomarkers for PIK3CA-mutated BC. The gene discussed is PIK3CA; the disease is neoplasm.